Northern Trust’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-339,391
| Closed | -$1.53M | – | 4435 |
|
|
2025
Q4 | $1.53M | Sell |
339,391
-15,303
| -4% | -$78.4K | ﹤0.01% | 3147 |
|
|
2025
Q3 | $1.91M | Sell |
354,694
-37,353
| -10% | -$202K | ﹤0.01% | 3063 |
|
|
2025
Q2 | $2.13M | Buy |
392,047
+335,684
| +596% | +$1.33M | ﹤0.01% | 2944 |
|
|
2025
Q1 | $156K | Sell |
56,363
-3,737
| -6% | -$13K | ﹤0.01% | 4004 |
|
|
2024
Q4 | $205K | Buy |
60,100
+29,759
| +98% | +$85.8K | ﹤0.01% | 3985 |
|
|
2024
Q3 | $89.2K | Sell |
30,341
-1,274
| -4% | -$4.2K | ﹤0.01% | 4087 |
|
|
2024
Q2 | $107K | Sell |
31,615
-4,200
| -12% | -$13.7K | ﹤0.01% | 4037 |
|
|
2024
Q1 | $109K | Sell |
35,815
-8,341
| -19% | -$29.3K | ﹤0.01% | 4056 |
|
|
2023
Q4 | $186K | Buy |
+44,156
| New | +$240K | ﹤0.01% | 3921 |
|
|
2023
Q3 | – | Sell |
-84,688
| Closed | -$882K | – | 4481 |
|
|
2023
Q2 | $882K | Buy |
84,688
+994
| +1% | +$8.89K | ﹤0.01% | 3406 |
|
|
2023
Q1 | $583K | Sell |
83,694
-1,166
| -1% | -$10.2K | ﹤0.01% | 3402 |
|
|
2022
Q4 | $512K | Sell |
84,860
-1,304
| -2% | -$9.63K | ﹤0.01% | 3501 |
|
|
2022
Q3 | $679K | Buy |
+86,164
| New | +$1M | ﹤0.01% | 3409 |
|
|
2022
Q2 | – | Sell |
-112,749
| Closed | -$2.21M | – | 4758 |
|
|
2022
Q1 | $2.21M | Buy |
112,749
+5,588
| +5% | +$112K | ﹤0.01% | 3046 |
|
|
2021
Q4 | $3.68M | Sell |
107,161
-1,832
| -2% | -$73.7K | ﹤0.01% | 2889 |
|
|
2021
Q3 | $5.95M | Sell |
108,993
-36,021
| -25% | -$2.17M | ﹤0.01% | 2622 |
|
|
2021
Q2 | $10.7M | Buy |
+145,014
| New | +$14.5M | ﹤0.01% | 2319 |
|
Northern Trust's CVAC Position: Q1 2026 in Review
Northern Trust sold out of CureVac (CVAC) in Q1 2026, closing a stake of 339,391 shares — an estimated $1.53M sold.
Northern Trust first reported a position in CVAC in Q2 2021 and held it in 17 quarters. The position peaked at $10.7M in Q2 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Northern Trust reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Northern Trust sold 339,391 CureVac shares in Q1 2026, an estimated $1.53M.
- Northern Trust first reported a position in CureVac in Q2 2021 and held it in 17 quarters.
- Northern Trust's CureVac position peaked at $10.7M in Q2 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.